TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Onkologia AB
Closing information (x1000 NOK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
1,272
|
1,520
|
1,405 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,031
|
1,311
|
1,258 |
| EBITDA |
1,017
|
1,296
|
1,194 |
| Total assets |
5,495
|
4,827
|
3,803 |
| Current assets |
1,283
|
1,638
|
1,458 |
| Current liabilities |
56
|
144
|
160 |
| Equity capital |
5,438
|
4,683
|
3,643 |
| - share capital |
53
|
51
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
99.0%
|
97.0%
|
95.8% |
| Turnover per employee |
1,272
|
1,520
|
1,405 |
| Profit as a percentage of turnover |
81.1%
|
86.2%
|
89.5% |
| Return on assets (ROA) |
18.8%
|
27.2%
|
33.1% |
| Current ratio |
2291.1%
|
1137.5%
|
911.2% |
| Return on equity (ROE) |
19.0%
|
28.0%
|
34.5% |
| Change turnover |
-298
|
37
|
218 |
| Change turnover % |
-19%
|
2%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.